In Brief: PLC Systems
This article was originally published in The Gray Sheet
Executive SummaryPLC Systems: Firm's Heart Laser transmyocardial revascularization system likely will need to undergo a second review by FDA's Circulatory System Devices Panel, Robert Rudko, PhD, chairman and chief scientific officer, stated Oct. 27 at the Oppenheimer & Co. conference in New York City. Following the panel's July "not approvable" recommendation, FDA requested additional data to support a February 1997 premarket approval application. The panel called for 12 month follow-up on 200 patients ("The Gray Sheet" Aug. 4, p. 7). PLC Systems has collected the data and is preparing to submit it in November, Rudko said...
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.